Article
Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.
PloS one - 11 Feb 2010
Morine Kevin J, Bish Lawrence T, Pendrak Klara, Sleeper Meg M, Barton Elisabeth R, Sweeney H Lee
Abstract excerpt
BACKGROUND: Myostatin inhibition is a promising therapeutic strategy to maintain muscle mass in a variety of disorders, including the muscular dystrophies, cachexia, and sarcopenia. Previously described approaches to blocking myostatin signaling include injection delivery of inhibitory propeptide domain or neutralizing antibodies. METHODOLOGY/PRINCIPAL FINDINGS: Here we describe a unique method of myostatin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
